![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16396-16402, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 28, 2002, and in revised form, February 21, 2002
Sialic acid containing glycosphingolipids
(gangliosides) are expressed on the surface of all mammalian cells and
have been implicated in regulating various biological phenomena;
however, the detailed signaling mechanisms involved in this process are not known. We report here a novel aspect of disialoganglioside, GD3-mediated regulation of cell proliferation and cell death via the
recruitment of reactive oxygen species (ROS). A low
concentration (2.5-10 µM) of GD3, incubated with
human aortic smooth muscle cells for a short period of time (10-30
min), stimulates superoxide generation via the activation of both NADPH
oxidase and NADH oxidase activity. This leads to downstream signaling
leading to cell poliferation and apoptosis. However,
[3H]GD3 incubated with the cells under such conditions
was found in a trypsin-sensitive fraction that was separable from
endogenous GD3. The exact mechanism causing ROS generation and
downstream signaling remains to be elucidated. The uptake of GD3 was
accompanied by a 2.5-fold stimulation in the activity of
mitogen-activated protein (MAP) kinase and 5-fold stimulation in cell
proliferation. Preincubation of cells with membrane-permeable
antioxidants, pyrrolidine dithiocarbamate, and
N-acetylcysteine abrogated the superoxide generation and
cell proliferation. In contrast, at higher concentrations (50-200
µM) GD3 inhibited the generation of superoxides but
markedly stimulated the generation of nitric oxide (NO) (10-fold
compared with control). This in turn stimulated mitochondrial
cytochrome c release and intrachromosomal DNA
fragmentation, which lead to apoptosis. In sum, at a low
concentration, GD3 recruits superoxides to activate p44 MAPK and
stimulates cell proliferation. In contrast, at high concentrations GD3
recruits nitric oxide to scavenge superoxide radicals that triggered
signaling events that led to apoptosis. These observations might have
relevance in regard to the potential role of GD3 in aortic smooth
muscle cell proliferation and apoptosis that may contribute to plaque
rupture in atherosclerosis.
Glycosphingolipids
(GSL)1 are ubiquitously
expressed components of mammalian plasma membranes and have been
implicated in the control of cell growth regulation through modulation
of transmembrane signaling (1-3). Gangliosides are a species of GSL
that contain sialic acids. GD3 is a disialogaglioside implicated in
cell growth and proliferation. GD3 is overexpressed in some tumors,
such as human melanoma in which it serves as a tumor antigen (4-8).
Increased levels of GD3 have also been associated with proliferative
diseases like atherosclerosis (9, 10). Recently, it was reported that the endogenous expression of GD3 synthase leads to proliferation of
PC12 cells through the Ras-MAPK pathway (11). On the other hand, the
overexpression of GD3 synthase leads to an increased level of GD3 that
in turn contributes to apoptosis in human leukemic cells (12). In
addition, studies suggest that GD3 mediates TNF- Reactive oxygen species (ROS) are usually generated in response to
diverse external stimuli, such as TNF- In this paper, we report that exogenously supplied
[3H]GD3 associates with the cell membrane mainly in a
trypsin-sensitive state. Subsequently, it recruits ROS's such
as O Isotopes and Chemicals--
[3H]Thymidine and
[ Cells--
Human aortic smooth muscle cells were prepared and
cultured in minimal essential medium supplemented with 10% fetal calf
serum, penicillin (100 µg/ml), streptomycin (100 µg/ml), and
glutamine (50 µg/ml) according to the procedure of Ross (19).
Vehicle for Gangliosides--
Stock solutions of gangliosides
were prepared in dimethyl sulfoxide (Me2SO) and added to
cultured cells to achieve the final desired concentrations of
gangliosides. The maximum concentration of Me2SO exposed to
cells was <0.01%, and cells that were incubated with 0.01%
Me2SO served as a control.
Incorporation of [3H] GD3 into Human Aortic Smooth
Muscle Cells--
The incorporation of [3H]GD3 into
human aortic smooth muscle cells was carried out exactly as described
by Sonderfeld et al. (20). Briefly, confluent monolayer of
aortic smooth muscle cells were incubated in minimum essential medium
containing 0.3% heat-inactivated fetal bovine serum and 200 nmol of
[3H]GD3. At 1-, 2.5-, 5-, 10-, 20-, and 30-min time
intervals medium was removed, and the monolayers were washed three
times with ice-cold phosphate-buffered saline. Total radioactivity in
the washed cell pellets was measured by scintillation spectrometry
using Aquasol-II as the scintillation fluid (PerkinElmer Life
Sciences). Next the cells were harvested following
trypsinization (0.25% trypsin for 15 min at 37 °C and centrifuged
(1,000 × g for 5 min, 4 °C). The cell pellets were
washed three times with phosphate-buffered saline, centrifuged, and
radioactivity associated with the cells was measured by scintillation spectrometry.
Measurement of Superoxide Production in Intact
Cells--
Lucigenin, an acridylium compound (Sigma) that emits light
on reduction and interaction with O Cell Fractionation and NADH/NADPH Oxidase Assay--
Confluent
human A-SMC was incubated with 5 µM GD3. At different
time intervals cells were harvested and homogenized in a lysis buffer
containing 20 mM potassium phosphate buffer, pH 7.0, 1 mM EGTA, 10 µg/ml aprotinin, 0.5 µg/ml leupeptin, 0.7 µg/ml pepstatin, and 0.5 mM phenylmethylsulfonyl
fluoride. The membrane (both plasma membrane and mitochondrial) and
cytosol were prepared by the centrifugation of the cell homogenate at
29,100 × g for 20 min at 4 °C (15). The membrane
was resuspended in an original volume of lysis buffer. NADH and NADPH
oxidase activity was measured in both cytosolic and membrane fraction
as described previously by the lucigenin chemiluminescence method (15)
using 250 µM lucigenin as the electron acceptor and
either 100 µM NADPH or 100 µM NADH as an electron donor. In some experiments, NADPH oxidase activity was measured in the membrane preparations in the presence of 1 mM rotenone (mitochondrial poison). The protein content was
measured by the Lowry et al. (21) method with bovine serum
albumin serving as the standard.
Immunoprecipitation and MAP Kinase Activity Assay--
A-SMC was
lyzed in 100 µl of radioimmune precipitation buffer containing 150 mM NaCl, 5 mM EGTA, 5 mM EDTA, 10 mM sodium fluoride, 1 mM
Na3VO4, 1 mM phenylmethylsulfonyl
fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 µg/ml
pepstatin, 25 mM Tris/HCl, pH 7.4, 1% Triton X-100, and
Nonidet P-40. The lysate was centrifuged and immunoprecipitated with
the anti-MAP kinase antibody conjugated with agarose as described
earlier (22). Immunocomplex was directly used for MAP kinase activity
assay (22). Briefly, 25 µl of total reaction mixture contained 1 mg/ml myelin basic protein peptide (APRTPGGRR), 50 µM
[ Internucleosomal DNA Fragmentation Assay--
Cells were treated
with various agonists and antagonists for 12 h, and the DNA was
isolated and analyzed by DNA electrophoresis as described earlier (23).
Cytochrome c Release Assay--
Following incubation with
agonists, cells were washed, harvested in ice-cold phosphate-buffered
saline, and suspended in 100 µl of extraction buffer containing 20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 5 mM EDTA, 5 mM
dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, and
0.25 mM sucrose (24). Cytosol was prepared, and the level
of cytosolic cytochrome c was determined by Western blotting
using a monoclonal anti-cytochrome c antibody.
Measurement of Nitric Oxide Production--
Nitrite production,
a stable product of NO, was measured by the Griess reagent as described
previously (25). The cells were incubated with the agonist and
antagonists. At the end of incubation, 500 µl of culture medium was
mixed with an equal volume of Griess reagent (1 part of 1%
sulfanilamide in 2.5% phosphoric acid and 1 part of 0.1%
naphthylethylenediamine dihydrochloride). The colorimetric absorbance
at 550 nm was measured, and the nitrite concentration was determined
using a standard curve generated using sodium nitrite.
Time Kinetics of [3H]GD3 Incorporation into Human
Aortic Smooth Muscle Cells--
As shown in Fig.
1 (top panel), total
incorporation of [3H]GD3 into human aortic smooth muscle
cells occurred very rapidly during the 30-min duration of this study.
However, very little radioactivity remained associated with the cells
following trypsinization of cells (Fig. 1, bottom
panel).
Effects of Gangliosides on Superoxide Generation--
GD3 (10 µM) stimulated the level of O Effects of Time and Concentration of GD3 on Superoxide Production
and GSH Levels--
GD3 stimulated the generation of O Effect of GD3 on NADPH/NADH Oxidase Activity--
Cell membranes
were prepared at varying time intervals after being incubated in A-SMC
with/without GD3 (10 µM) and NADPH/NADH oxidase activity
was measured. Following a lag time of about 2.5 min, NADPH/NADH oxidase
activity increased linearly up to 10 min in cells incubated with GD3
(Fig. 4, A and B).
The maximum increase in NADPH oxidase activity (4-fold compared with
control) was observed after 10-15-min incubation of cells with GD3
(Fig. 4A) and reached a plateau. Thereafter, there was no
NADPH oxidase activity observed in the cytosolic fraction in cells
incubated with and without GD3 (data not shown). GD3 maximally
increased (1.8-fold) the activity of NADH oxidase in H-ASMC as compared
with the control (Fig. 4B) following incubation for 10 min.
These time kinetics data were obtained using 10 µM GD3.
However, at a relatively higher concentration (100 µM),
GD3 decreased the activity of NADPH oxidase to approximately one-half-the control value (data not shown). And this may in part explain a decrease in O Effect of GD3 on MAP Kinase Activity and Cell
Proliferation--
Fig. 5A
represents the phosphorylation of the myelin basic protein peptide
(APRTPGGRR) by immunoprecipitated cell lysate following stimulation
with various concentrations of GD3. A
concentration-dependent increase in MAPK activity was
observed up to a concentration of about 10 µM GD3.
However, we observed a progressive decline in the level of
phosphorylated MBP in cells incubated with 50-200 µM of GD3 (Fig. 5B). In fact, at a
concentration of 100 µM GD3, MBP phosphorylation fell
below the control value. As shown in Fig. 5B, GD3 (10 µM) exerted a time-dependent stimulation in
the activity of MAPK. Interestingly, preincubation of cells with
cell-permeable antioxidant N-acetylcysteine and PDTC
abrogated GD3 (10 µM) induced MAPK activity (Fig.
5C). GD3 (10 µM) exerted about a 5-fold
increase in the incorporation of [3H]thymidine in A-SMC,
an index of cell proliferation (Fig. 5D). Preincubated cells
with PDTC and NAC completely abrogated GD3 induced increase in
[3H]thymidine incorporation.
Effect of GD3 Concentration on Nitric Oxide in
A-SMC--
Following the incubation of A-SMC with 10 µM
GD3 for 12 h, there was no production of NO (Fig.
6A). However, at higher
concentrations (50-200 µM) GD3 markedly stimulated NO
production. A maximum of 5-fold stimulation in NO production was
observed with 100-200 µM GD3 (relative to control); this
was within the range of stimulation of NO by LPS (10 µg/ml) and
interferon- Effect of GD3 on the Release of Cytochrome c--
At a
concentration of 10 µM, GD3 did not induce the release of
cytochrome c from the motochondria to cytosol. However, as we increased the concentration (50-200 µM) of GD3, a
progressive increase in the level of cytochrome c release in
cytosol was observed (Fig. 7). As a
control we used C2-ceramide (1 µM), which
also stimulated the release of mitochondrial cytochrome c in
these cells.
Although glycosphingolipids have been shown to be present in
mammalian cells their functional role in cell proliferation, adhesion
and programmed cell death (apoptosis) are only beginning to emerge (1,
2, 26, 27). GD3 is a disialoganglioside that is enriched in human
aortic smooth muscle cells. However, in pathological conditions such as
in human melanomas and in atherosclerotic plaques, the level of GD3 is
markedly elevated (9, 27). In the present study we explain signaling
mechanisms by which GD3 can induce aortic smooth muscle cell
proliferation as well as apoptosis.
Previous studies employing subcellular fractionation, cell surface
labeling, and electron microscope techniques have shown that
gangliosides are predominately associated with the plasma membrane
(27). The employment of freeze-fracture techniques revealed that
globotriosylceramide is localized as microaggregates on the surface of
erythrocytes (28). Employing [3H]GD3 in this study we
have shown that during early time periods (10-30 min) of incubation,
this ganglioside was associated mainly with a trypsin-sensitive cell
surface component. Our studies confirm a previous report in human skin
fibroblasts in which [3H]GM1 radioactivity was also found
to associate with human skin fibroblast in a trypsin-sensitive state.
However, upon long term (24 h or more) incubation [3H]GM1
radioactivity was found to reside in trypsin-resistant state in cell
membranes. The validity of the trypsinization procedure employed was
established by electron spin resonance studies (29). We have not
identified the chemical nature of GD3 binding cell surface component,
but speculate it to be a glycopeptide/glucan. This speculation is based
on a previous observation that a novel carbohydrate-glycosphingolipid
interaction occurs between a The relevance of the uptake of [3H]GD3 kinetics with free
radicals and cell signaling became evident when we observed that within
5 to 10 min of incubation with GD3 a 2-and 3-fold increase in the
generation of superoxide occurred (Fig. 3). These findings suggest that
the association of exogenously supplied GD3 to A-SMC cell surface was
critical for the production of superoxide. This was accompanied by the
activation/phosphorylation of MAPK and other downstream events that
collectively contributed to A-SMC proliferation. This phenotypic change
could be abrogated by preincubation of cells with NADPH oxidase
inhibitor; diphenylene iododium, scavenger of free radicals;
N-acetylcysteine; and a membrane permeable antioxidant such
as PDTC (15). It may also be possible that GD3 molecules inserted into
the plasma membrane (and which may well be in the range of about 1 mol%) are responsible for the formation of ROS, in particular in view
of its likely distribution in so called rafts, where its concentration
would be even higher. On the other hand, a cross-linking of surface
proteins by surface-adhering GD3 micelles may evoke these effects by
mimicking transmemmbrane signaling.
Why the exogenous supply of GD3 is required to bring about the
generation of superoxide and cell proliferation when A-SMC have
significant levels of endogenous GD3 is not clear to us at the present
time. However, we have conducted preliminary studies employing wild
type Chinese hamster ovary cells and mutant cells (SPB-1) that are
devoid of LacCer and GD3 to address this issue. We observed that the
basal level of superoxide generated (without exogenous supply of
LacCer/GD3) in wild type and mutant cells was very low. However, upon
the addition of exogenous LacCer/GD3 (10 µM) the mutant
cells and wild type cells produced a 2-5-fold higher level of
O Lipid second messenger such as LacCer and GD3 have been shown to be
produced in cells upon the activation of glycosphingolipid glycosyltransferases by cytokines. For example, we showed that incubation of human umbilical vein endothelial cells with TNF- Previously, the release of cytochrome c from mitochondria to
cytosol has been implicated in the apoptotic process. Interestingly, a
cell-permeable ceramide (C2-ceramide) also stimulated the
release of cytochrome c in our studies but did not generate
ROS or NO. This is most likely explained by the observation that
ceramide may be converted to GD3, which in turn produces NO to induce
apoptosis (11). Collectively, these lines of evidence provide strong
support for the hypothesis that GD3 recruits NO to induce apoptosis in cultured H-ASMC.
Reduced GSH is a tripeptide antioxidant, which is present in all
mammalian cells at a concentration between 1 and 10 mM
(34). The predominant role of GSH is to provide a reduced environment inside the cell and to protect cells from redox stress. Our studies indicate that at higher concentration, GD3 exerts a
concentration-dependent decrease in the level of GSH. This
may also contribute to the process of apoptosis.
Because apoptosis can be induced in a number of cell systems by
hydrogen peroxide, we measured the effects of GD3 on hydrogen peroxide
levels. We found that although at low concentrations (10 µM), GD3 stimulated hydrogen peroxide levels, at high
concentrations (100-200 µM) it reduced the cellular
level of hydrogen peroxides (data not shown). Thus, these studies
suggested that GD3 might not employ hydrogen peroxide or superoxide to
induce death. On the other hand, previous studies have shown that
exposure of cells to a variety of agonists such as pyrogallol, a
generator of ROS, increases the DNA binding activity of NFkB that is
followed by an increase in an inducible nitric-oxide synthase mRNA
(35). Elevated levels of nitric oxide, in turn, stimulated apoptosis. This tenet was substantiated further by determining the effects of GD3
on the levels of nitric oxide by directly measuring the levels of
nitrate as well as inducible nitric-oxide synthase levels by
Western immunoblot assays. Although GD3 did not induce inducible nitric-oxide synthase in A-SMC and nitrite production at low
concentrations, at high concentrations, GD3 stimulated nitric oxide
production. Previous studies have indicated that nitric oxide serves as
a scavenger of O In summary, nonstimulated SMCs produce very low levels of O *
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Pediatrics, Lipid Research Atherosclerosis Unit, Sphingoglycolipid
Signaling and Vascular Biology Laboratory, 550 N. Broadway, Suite 312, Baltimore, MD 21205. Tel.: 410-614-2518; Fax: 410-614-2826; E-mail:
chatter@jhmi.edu.
Published, JBC Papers in Press, February 22, 2002, DOI 10.1074/jbc.M200877200
2
A. Bhunia, G. Sato, and S. Chatterjee,
unpublished observations.
The abbreviations used are:
GSL, glycosphingolipid;
MAP, mitogen-activated protein;
MAPK, MAP kinase;
PDTC, pyrrolidine dithiocarbamate;
NAC, N-acetylcysteine;
NO, nitric oxide;
ROS, reactive oxygen species;
A-SMC, aortic smooth
muscle cell;
NMLA, NG-monomethyl-L-arginine;
GSH, reduced glutathione;
TNF, tumor necrosis factor;
MOPS, 4-morpholinepropanesulfonic acid;
PDTC, pyrrolidine dithiocarbamate;
D-PDMP, D-threo-L-phenyl-2-decanoylamino-3-morpholino-1-propanol.
GD3 Recruits Reactive Oxygen Species to Induce Cell Proliferation
and Apoptosis in Human Aortic Smooth Muscle Cells*
,
¶
Department of Pediatrics, Lipid Research
Atherosclerosis Unit, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21044 and the
§ Kekulé-Institut für Organische Chemie und
Biochemie der Universität Bonn, D-53121 Bonn, Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
- and
Fas/Apo-1/CD-95-induced apoptosis in such cells. Collectively, these
studies imply that GD3 might have a dual role in modulating cell
proliferation and apoptosis. However, the signaling mechanisms involved
in this phenomenon have not been evaluated. We rationalized that
because cultured human aortic smooth muscle cells and normal human
aorta contain a significant amount of GD3, it may well be implicated in
proliferation. On the other hand a marked increase in the level of GD3
in human plaque from patients with atheroscleosis may contribute to
plaque instability via inducing apoptosis.
, TGF-
, PDGF, EGF (13), and
lipid second messengers, e.g. lysophosphadic acid (14)
and lactosylceramide (15). At low concentrations ROS may play the role
of an intracellular messenger of various molecular events (16),
including cell proliferation and apoptosis. However, the generation of
large amounts of ROS is considered cytotoxic and contributes to
apoptosis. ROS represents multiple molecular species, including singlet
oxygen, superoxides (O
), the thiperoxyradical
(RSOO·), and the hydroxyl radical (HO·). Superoxides are
the early molecular species of ROS that are generated as a consequence
of the interaction of cells with external stimuli that in turn generate
H202, HO·, etc. The generation of ROS
has been related to the activation of transcriptional factors, for
example, AP-1, NF
B, and mitogen-activated protein kinase (p44 MAPK)
implicated in cell proliferation. On the other hand, NO as well as the
generation of high levels of O

![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (222 TBq/mmol) were purchased from Amersham
Biosciences. Bovine milk GD3 was purchased from Matreya (Pleasant Gap, PA) and labeled with 3H, employing
palladium-catalyzed reduction of the sphingosine double bond
(18). [3H]GD3 was purified further by chromatography in
silica gel Lichro prep Si60 (E. Merck, AG Darmstadt, Germany) with
choloroform/methanol/water (60:40:9, v/v). The specific activity of the
[3H]GD3 was 147.9 MBq/µmol. A stock solution of GD3 was
prepared in dimethyl sulfoxide and suitable aliquots added to the
culture dishes. Anti-MAPK antibody (specific for p44 MAPK and p42
MAPK), and MAPK-specific substrate peptides (APRTPGGRR), were obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Anti-cytochrome c antibody was obtained from PharMingen (San Diego, CA). The
DNA isolation kit was purchased form Qiagen Inc. GSL and all other chemicals were purchased from Sigma.


-32P]ATP (1,800 cpm/pmol), 0.5 mM
adenosine 3',5'-cyclic monophosphate-dependent protein
kinase inhibitor, and assay dilution buffer containing 30 mM
-glycerophosphate, 20 mM MOPS, pH 7.2, 20 mM MgCl2, 5 mM EGTA, 1 mM dithiothreitol, 0.5 mM
Na3VO4, and 2-3 µg of immunoprecipitated protein. The reaction was initiated upon the addition of
[
-32P] ATP for 15 min at 30 °C and terminated with
the addition of 10 µl of ice-cold 40% trichloroacetic acid. One part
of the reaction mixture was spotted onto p81 phosphocellulose paper.
Free [
-32P]ATP was removed by five washes (5 min each)
with 1% phosphoric acid and counted in a scintillation counter. The
remaining part of the reaction mixture was run into 15% SDS-PAGE, and
the gel was dried and autoradiographed.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (16K):
[in a new window]
Fig. 1.
Uptake kinetics of [3H]GD3 into
human aortic smooth muscle cells. The cells were incubated at
37 °C with 50 µM GD3. At the indicated time periods,
total cell-associated radioactivity (top panel) and
trypsin-resistant radioactivity was measured by scintillation
spectrometry.





View larger version (15K):
[in a new window]
Fig. 2.
Effect of various gangliosides on generation
of superoxide in H-ASMC. When 80-90% confluent, H-ASMC were
harvested and suspended in balanced salt solution. Intact cell
suspensions were placed in a 96-well black microtiter plate (Packard)
for the measurement of O 

, vehicle;
,
treatments.










View larger version (23K):
[in a new window]
Fig. 3.
Effect of time and concentrations of GD3 on
the production of superoxide in H-ASMC. Intact cell suspension was
prepared as described in legend to Fig. 1. A, generation of
O 
), GD3 (
). B, rate of generation of O
in intact cells at different time intervals, as indicated:
,
vehicle;
, GD3 (10 µM). C, rate of
generation of O
) and
different concentrations of GD3 (
).


View larger version (16K):
[in a new window]
Fig. 4.
Effect of GD3 on NADPH/NADH oxidase activity
in H-ASMC. Cells were incubated with/without 10 µM
GD3 at different time intervals, as indicated, and plasma membrane and
cytosol were prepared, as described under "Materials and Methods."
NADPH/NADH oxidase activity was measured in both membrane and cytosolic
fraction by the rate of generation of O 
), GD3- (10 µM) stimulated (
) cells, DPI (
), and DPI + GD3 (10 µM) (
). B, NADH oxidase activity in
membrane fraction of both nonstimulated (vehicle only) (
) and GD3-
(10 µM) stimulated (
) cells. NADPH/NADH oxidase
activity in the cytosolic fraction of incubated cells remained
unchanged (data not shown).

View larger version (15K):
[in a new window]
Fig. 5.
Effect of GD3 on MAP kinase activity and cell
proliferation. Following stimulation of cells with GD3, cell
lysate was prepared and immunoprecipitated as described under
"Materials and Methods." Activity assay of MAPK was done by MBP
(sequence APRTPGGRR) phosphorylation. A, MBP phosphorylation
by various concentrations of GD3. B, MAPK activity at
different time intervals measured by direct counting vehicle (
) (10 µM) and GD3 (10 µM) stimulated (
)
cells. C, assay of MAPK activity following incubation
with NAC (15 mM) for 30 min, PDTC (100 µM)
for 1 h, followed by incubation with 10 µM GD3.
D, cells were incubated with 10 µM GD3 for
18 h. Next, [3H]thymidine incorporation was measured
as described under "Materials and Methods." In some experiments
cells were preincubated with 100 µM PDTC for 1 h or
15 mM NAC for 30 min before incubation with 10 µM GD3 for 18 h. Each point is the mean + S.D. of
three separate experiments.
(200 units/ml) for 24 h. GD3-induced NO production
was completely inhibited by preincubation of cells with 200 µM
NG-monomethyl-L-arginine (NMLA)
(Fig. 6B). The incubation of A-SMC with GD3 (0-10
µM) had no effects on apoptosis/DNA ladder formation (Fig. 6C). However, at higher concentration (100-200
µM) GD3 markedly stimulated the intranucleosomal DNA
degradation after 24 h, which was abrogated by preincubation of
cells with NMLA (200 µM) (Fig. 6C).

View larger version (17K):
[in a new window]
Fig. 6.
Effect of GD3 on nitric oxide production and
apoptosis. Following incubation with different concentrations of
GD3 as indicated for 24 h, nitrite production was measured by
griess reagent (A).
, vehicle;
, GD3.
B, NMLA inhibited GD3-induced NO production. C,
DNA ladder formation by different concentrations of GD3, as
indicated.

View larger version (23K):
[in a new window]
Fig. 7.
Effect of GD3 on cytosolic cytochrome
c concentration. Cytosolic cytochrome
c concentration was measured as described under "Materials
and Methods" using different concentrations of GD3.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-(1-3) glucan immunomodulator,
PGG-glucan, and lactosylceramide in human leukocytes (30).


activated LacCer synthase and generated LacCer. In turn, LacCer activated NADPH oxidase to generate superoxide that was critical in the
expression of intercellular cell adhesion molecule (ICAM-1) and the
adhesion of neutrophils to human umbilical vein endothelial cells (31). This phenotypic change in cells treated with TNF-
was abrogated by preincubation with
D-threo-L-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), but was bypassed by LacCer presumably via the
generation of O

-induced O
was shown to increase the synthesis of GD3
~2-fold within 2 h of incubation and rendered the cells
apoptotic (32). Moreover, apoptosis was abrogated in rat hepatocytes by
the use of P-PMP. Mechanistic studies pursued further employing rat
hepatocyte mitochondria revealed that GD3 stimulated the generation of
hydrogen peroxide within 15-30 min and enhanced the permeability of
mitochondrial membrane to release cytochrome c (33). We also
found that incubation of A-SMC with large concentrations of GD3
stimulated the release of cytochrome c that in turn may have
contributed to apoptosis (see below).

) radicals with endogeneous O


. In turn, ONOO
induces apoptosis. This mechanism may also explain why the level of
O


![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Hakomori, S. I.,
and Igarashi, Y.
(1993)
Adv. Lipid Res.
25,
147-162[Medline]
[Order article via Infotrieve] 2.
Chatterjee, S.
(1998)
Arterioscler. Thromb. Vasc. Biol.
18,
1523-1533 3.
Pukel, C. S.,
Lloyd, K. O.,
Travassos, L. R.,
Dippold, W. G.,
Oettgen, H. F.,
and Old, L. J.
(1982)
J. Exp. Med.
155,
1133-1147 4.
Furukawa, K.,
and Lloyd, K. O.
(1990)
in
Human Melanoma: Immunology, Diagnostics and Therapy
(Ferrone, S., ed)
, pp. 15-30, Springer-Verlag, Heidelberg, Germany
5.
Nakakuma, H.,
Sanai, Y.,
Shiroki, K.,
and Nagai, Y.
(1984)
J. Biochem. (Tokyo)
96,
1471-1480 6.
Albino, A. P.,
Sozzi, G.,
Nanus, D. M.,
Jhanwar, S. C.,
and Houghton, A. N.
(1992)
Oncogene
7,
2315-2321[Medline]
[Order article via Infotrieve] 7.
Cheresh, D. A.,
Pytela, R.,
Pierschbacher, M. D.,
Klier, F. G.,
Ruoslaht, E.,
and Reisfeld, R. A.
(1987)
J. Cell Biol.
105,
1163-1173 8.
Nakano, J.,
Mohan-Raj, B. K.,
Asagami, C.,
and Lloyd, K. O.
(1996)
J. Invest. Dermatol.
107,
543-548[CrossRef][Medline]
[Order article via Infotrieve] 9.
Mukhin, D.,
Chao, F. F.,
and Kruth, H. S.
(1995)
Arterioscler. Thromb. Vasc. Biol.
15,
1607-1615 10.
Chatterjee, S.,
Dey, S.,
Shi, W. Y.,
Thomas, K.,
and Hutchins, G. M.
(1996)
Glycobiology
7,
57-65 11.
Fukumoto, S.,
Mutoh, T.,
Hasegawa, T.,
Miyazaki, H.,
Okada, M.,
Goto, G.,
Furukawa, K.,
Urano, T.,
and Furukawa, K.
(2000)
J. Biol. Chem.
275,
5832-5837 12.
Maria, R. D.,
Lenti, L.,
Malisan,
d'Agostion, F.,
Tomassini, B.,
Zeuner, A.,
Rippo, M. R.,
and Testi, R.
(1997)
Science
277,
1652-1655 13.
Schreck, R.,
and Baeuerle, P. A.
(1991)
Trends Cell Biol.
1,
39-42[CrossRef][Medline]
[Order article via Infotrieve] 14.
Sundaresan, M., Yu, Z. X.,
Ferrans, V.,
Irani, K.,
and Finkel, T.
(1995)
Science
270,
296-299 15.
Bhunia, A. K.,
Han, H.,
Snowden, A.,
and Chatterjee, S.
(1997)
J. Biol. Chem.
272,
15642-15649 16.
McCord, J. M.
(1993)
Clin. Biochem.
26,
351-357[CrossRef][Medline]
[Order article via Infotrieve] 17.
Chatterjee, S.
(2000)
Methods Enzymol.
311,
73-81[CrossRef][Medline]
[Order article via Infotrieve] 18.
Schwarzmann, G.
(1978)
Biochim. Biophys. Acta
529,
106-114[Medline]
[Order article via Infotrieve] 19.
Ross, R.
(1971)
J. Cell Biol.
50,
172-186 20.
Sonderfeld, S.,
Conzelmann, E.,
Schwarzmann, G.,
Hinrichs, U.,
and Sandhoff, K.
(1985)
Eur. J. Biochem.
149,
247-255[Medline]
[Order article via Infotrieve] 21.
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275 22.
Bhunia, A. K.,
Han, H.,
Snowden, A.,
and Chatterjee, S.
(1996)
J. Biol. Chem.
271,
10660-10666 23.
Selins, K. S.,
and Cohen, J. J.
(1987)
J. Immunol.
139,
3199-3206[Abstract] 24.
Zhang, P.,
Liu, B.,
Kang, S. W.,
Seo, M. S.,
Rhee, S. G.,
and Obeid, L. M.
(1997)
J. Biol. Chem.
272,
30615-30618 25.
Khan, B. V.,
Harrison, D. G.,
Olbrych, M. T.,
Alexander, R. W.,
and Medford, R. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9114-9119 26.
Hannun, Y.
(1994)
J. Biol. Chem.
269,
3125-3128 27.
Hakomori, S. I.
(1990)
J. Biol. Chem.
265,
18713-18716 28.
Tillack, T. W.,
Allietta, M.,
Moren, P. E.,
and Young, W. W.
(1993)
Biochim. Biophys. Acta
793,
15-24 29.
Schwarzmann, G.,
Hoffman-Bleihauer, P.,
Schubert, J.,
Sandhoff, K.,
and Marsh, D.
(1983)
Biochemistry
22,
5041-5048[CrossRef][Medline]
[Order article via Infotrieve] 30.
Zimmerman, J. W.,
Lindermuth, J.,
Fish, P. A.,
Palace, G. P.,
Stevenson, T. T.,
and Demong, D. E.
(1998)
J. Biol. Chem.
273,
22014-22020 31.
Bhunia, A. K.,
Arai, T.,
Bulkley, G.,
and Chatterjee, S.
(1998)
J. Biol. Chem.
273,
34349-34357 32.
Garcia-Ruiz, C.,
Colell, A.,
Paris, R.,
and Fernandez-Checa, J. C.
(2000)
FASEB J.
14,
847-858 33.
Garcia-Ruiz, C.,
Paris, R.,
Colell, A.,
and Fernandez-Checa, J.
(1999)
Hepatology
30,
411A 34.
Hockenbery, D. M.,
Oltvai, Z. N.,
Yin, X. M.,
Milliman, C. L.,
and Korsmeyer, S. J.
(1993)
Cell
75,
241-251[CrossRef][Medline]
[Order article via Infotrieve] 35.
Kane, D. J.,
Sarafian, T. A.,
Anton, R.,
Hahn, H.,
Gralla, E. B.,
Valentine, J. S.,
Ord, T.,
and Bredesen, D. E.
(1993)
Science
262,
1274-1277
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Wang, Z. Sun, A. V. Li, and K. J. Yarema Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis: MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION, GM3 AND GD3 BIOSYNTHESIS, PROLIFERATION, AND APOPTOSIS, AND ERK1/2 PHOSPHORYLATION J. Biol. Chem., September 15, 2006; 281(37): 27016 - 27028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Moon, S.-K. Kang, and C.-H. Kim Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells FASEB J, July 1, 2006; 20(9): 1387 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Park, M.-J. Kim, Y.-H. Kang, S.-Y. Choi, J.-H. Lee, J.-A Choi, C.-M. Kang, C.-K. Cho, S. Kang, S. Bae, et al. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release Blood, February 15, 2005; 105(4): 1724 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Moon, H.-M. Kim, Y.-C. Lee, and C.-H. Kim Disialoganglioside (GD3) Synthase Gene Expression Suppresses Vascular Smooth Muscle Cell Responses via the Inhibition of ERK1/2 Phosphorylation, Cell Cycle Progression, and Matrix Metalloproteinase-9 Expression J. Biol. Chem., August 6, 2004; 279(32): 33063 - 33070. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, S.-G. Sampathkumar, M. B. Jones, J. K. Rhee, G. Baskaran, S. Goon, and K. J. Yarema Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells J. Biol. Chem., April 30, 2004; 279(18): 18342 - 18352. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang and F. L. Kiechle Glycosphingolipids in Health and Disease Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 3 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Wu, Y. Gu, Y. C. Xu, F. E. Nwariaku, and L. S. Terada Vascular Endothelial Growth Factor Causes Translocation of p47phox to Membrane Ruffles through WAVE1 J. Biol. Chem., September 19, 2003; 278(38): 36830 - 36840. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Di Sano, B. Fazi, G. Citro, P. E. Lovat, G. Cesareni, and M. Piacentini Glucosylceramide Synthase and Its Functional Interaction with RTN-1C Regulate Chemotherapeutic-induced Apoptosis in Neuroepithelioma Cells Cancer Res., July 15, 2003; 63(14): 3860 - 3865. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kudo, P. Rayman, C. Horton, M. K. Cathcart, R. M. Bukowski, M. Thornton, C. Tannenbaum, and J. H. Finke Gangliosides Expressed by the Renal Cell Carcinoma Cell Line SK-RC-45 Are Involved in Tumor-induced Apoptosis of T Cells Cancer Res., April 1, 2003; 63(7): 1676 - 1683. [Abstract] [Full Text] [PDF] |
||||